95 related articles for article (PubMed ID: 19538834)
1. [Diagnosis and prediction of lung cancer through different classification techniques with tumor markers].
Nie GJ; Feng FF; Wu YJ; Wu YM
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2009 May; 27(5):257-61. PubMed ID: 19538834
[TBL] [Abstract][Full Text] [Related]
2. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
[TBL] [Abstract][Full Text] [Related]
3. [Comparison and analysis of three classifying models for discrimination of lung cancer established by 6 tumor markers].
Feng F; Nie G; Wu Y; Wu Y
Wei Sheng Yan Jiu; 2009 Jul; 38(4):429-32. PubMed ID: 19689074
[TBL] [Abstract][Full Text] [Related]
4. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
5. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
6. Artificial neural networks and logistic regression as tools for prediction of survival in patients with Stages I and II non-small cell lung cancer.
Marchevsky AM; Patel S; Wiley KJ; Stephenson MA; Gondo M; Brown RW; Yi ES; Benedict WF; Anton RC; Cagle PT
Mod Pathol; 1998 Jul; 11(7):618-25. PubMed ID: 9688182
[TBL] [Abstract][Full Text] [Related]
7. Predicting breast cancer survivability: a comparison of three data mining methods.
Delen D; Walker G; Kadam A
Artif Intell Med; 2005 Jun; 34(2):113-27. PubMed ID: 15894176
[TBL] [Abstract][Full Text] [Related]
8. Artificial neural networks and decision tree model analysis of liver cancer proteomes.
Luk JM; Lam BY; Lee NP; Ho DW; Sham PC; Chen L; Peng J; Leng X; Day PJ; Fan ST
Biochem Biophys Res Commun; 2007 Sep; 361(1):68-73. PubMed ID: 17644064
[TBL] [Abstract][Full Text] [Related]
9. Predicting three-year kidney graft survival in recipients with systemic lupus erythematosus.
Tang H; Poynton MR; Hurdle JF; Baird BC; Koford JK; Goldfarb-Rumyantzev AS
ASAIO J; 2011; 57(4):300-9. PubMed ID: 21701272
[TBL] [Abstract][Full Text] [Related]
10. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
Pan QR; Zhang X; Xu ZF; Zheng S
Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
[TBL] [Abstract][Full Text] [Related]
11. [Value of combined detection of tumor markers for the prediction of small cell and non-small cell lung cancer].
Wu Y; Wu Y; Wang L; Qu L
Wei Sheng Yan Jiu; 2000 Jul; 29(4):213-5. PubMed ID: 12520921
[TBL] [Abstract][Full Text] [Related]
12. A comparison of performance of mathematical predictive methods for medical diagnosis: identifying acute cardiac ischemia among emergency department patients.
Selker HP; Griffith JL; Patil S; Long WJ; D'Agostino RB
J Investig Med; 1995 Oct; 43(5):468-76. PubMed ID: 8528758
[TBL] [Abstract][Full Text] [Related]
13. [Application of serum protein pattern model in diagnosis of colorectal cancer].
Chen YD; Zheng S; Yu JK; Hu X
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):417-20. PubMed ID: 15355647
[TBL] [Abstract][Full Text] [Related]
14. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N
Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318
[TBL] [Abstract][Full Text] [Related]
15. [Value of auto-fluorescence spectrum combined with tumor markers in diagnosis of lung cancer].
Wu YJ; Hao YH; Wu WC; Wu YM
Guang Pu Xue Yu Guang Pu Fen Xi; 2009 Oct; 29(10):2787-91. PubMed ID: 20038061
[TBL] [Abstract][Full Text] [Related]
16. [The value of serum tumor marker in the diagnosis of lung cancer].
Shi GL; Hu XL; Yue SD; Song CX
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):299-301. PubMed ID: 15996327
[TBL] [Abstract][Full Text] [Related]
17. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic value of combined detection of TPS, NSE and CEA in lung cancer].
Zheng H; He BF; Luo RC
Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):165-6. PubMed ID: 12581971
[TBL] [Abstract][Full Text] [Related]
19. [The diagnostic values of CA242 combining other tumor markers for lung cancer].
Zhang S; Ma Y; Yang X
Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):271-3. PubMed ID: 11775851
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of pancreatic carcinoma based on combined measurement of multiple serum tumor markers using artificial neural network analysis.
Yang Y; Chen H; Wang D; Luo W; Zhu B; Zhang Z
Chin Med J (Engl); 2014; 127(10):1891-6. PubMed ID: 24824251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
